Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

This summary is generated by an algorithm. If you find any mistakes, let us know.

Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals
UN

Unicorn Nest news

Oxford Finance Provides $125 Million Credit Facility to Kala Pharmaceuticals

Oxford Finance LLC (“Oxford”), a leading specialty finance firm that provides senior debt to life sciences and healthcare services companies worldwide, has announced the closing of a $125 million senior secured term loan with Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.
– Proceeds from the transaction will be used to refinance existing indebtedness and provide additional growth capital for the Kala’s marketing of its two approved ophthalmic products.

Source
1 2 3 58 59 60
Crunchbase icon

Content report

The following text will be sent to our editors: